Cwm, LLC Uni Qure N.V. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Cwm, LLC holds 247 shares of QURE stock, worth $15,788. This represents 0.0% of its overall portfolio holdings.

Number of Shares

247

Previous 234 5.56%

Holding current value

$15,788

Previous $3,000 366.67%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$13.28 - $59.4 $172 - $772	13 Added 5.56%	247 $14,000
Q4 2024 Feb 04, 2025	BUY	$4.54 - $17.73 $1,062 - $4,148	234 New	234 $4,000
Q2 2023 Aug 03, 2023	BUY	$11.12 - $22.2 $366 - $732	33 Added 550.0%	39 $0
Q1 2023 Apr 28, 2023	SELL	$18.7 - $23.07 $1,196 - $1,476	-64 Reduced 91.43%	6 $0
Q4 2022 Feb 01, 2023	BUY	$18.12 - $27.32 $1,268 - $1,912	70 New	70 $2,000
Q1 2022 Apr 21, 2022	SELL	$14.54 - $21.5 $3,475 - $5,138	-239 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$20.24 - $36.01 $4,837 - $8,606	239 New	239 $5,000

Others Institutions Holding QURE

# of Institutions

190

Shares Held

51.8M

Call Options Held

4.43M

Put Options Held

1.27M

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $2.99B
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account